Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
N/A
-275,000 Reduced 89.65%
31,746 $38,000
Q4 2023

Feb 13, 2024

SELL
N/A
-60,900 Reduced 16.56%
306,746 $123,000
Q3 2023

Nov 14, 2023

SELL
N/A
-69,280 Reduced 15.86%
367,646 $101,000
Q2 2023

Aug 11, 2023

BUY
$0.0 - $0.69 $0 - $14,075
20,400 Added 4.9%
436,926 $292,000
Q1 2023

May 12, 2023

BUY
$0.0 - $0.67 $0 - $25,058
37,400 Added 9.86%
416,526 $266,000
Q4 2022

Feb 13, 2023

BUY
$0.24 - $0.4 $1,680 - $2,800
7,000 Added 1.88%
379,126 $94,000
Q3 2022

Nov 14, 2022

SELL
$0.22 - $0.43 $1,092 - $2,135
-4,966 Reduced 1.32%
372,126 $86,000
Q2 2022

Aug 12, 2022

SELL
$0.26 - $0.37 $10,457 - $14,882
-40,223 Reduced 9.64%
377,092 $117,000
Q1 2022

May 13, 2022

SELL
$0.31 - $0.41 $174,713 - $231,072
-563,591 Reduced 57.46%
417,315 $151,000
Q4 2021

Feb 11, 2022

SELL
$0.38 - $0.68 $80,836 - $144,654
-212,727 Reduced 17.82%
980,906 $380,000
Q3 2021

Nov 12, 2021

SELL
$0.58 - $0.79 $804,266 - $1.1 Million
-1,386,666 Reduced 53.74%
1,193,633 $753,000
Q2 2021

Aug 13, 2021

SELL
$0.75 - $1.15 $509,946 - $781,918
-679,929 Reduced 20.86%
2,580,299 $2.06 Million
Q1 2021

May 13, 2021

BUY
$0.53 - $2.47 $1.01 Million - $4.72 Million
1,911,696 Added 141.76%
3,260,228 $3.55 Million
Q4 2020

Feb 10, 2021

BUY
$0.36 - $0.58 $301,619 - $485,942
837,832 Added 164.06%
1,348,532 $607,000
Q3 2020

Nov 13, 2020

SELL
$0.54 - $0.78 $306,367 - $442,530
-567,347 Reduced 52.63%
510,700 $298,000
Q2 2020

Aug 13, 2020

BUY
$0.47 - $0.86 $185,126 - $338,741
393,886 Added 57.57%
1,078,047 $599,000
Q1 2020

May 14, 2020

BUY
$0.53 - $0.99 $231,931 - $433,230
437,607 Added 177.49%
684,161 $363,000
Q4 2019

Feb 13, 2020

BUY
$0.3 - $0.69 $73,966 - $170,122
246,554 New
246,554 $154,000

Others Institutions Holding ISR

About Isoray, Inc.


  • Ticker ISR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 142,112,992
  • Market Cap $98.1M
  • Description
  • Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...
More about ISR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.